Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24

VEBIS HCW VE study group; Collaborators in VEBIS HCW study group

doi:10.2807/1560-7917.ES.2024.29.44.2400680

Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24

VEBIS HCW VE study group
, Collaborators in VEBIS HCW study group

additional collaborators of the VEBIS HCW VE study group are listed at the end of the article
These authors contributed equally to this work and share first authorship. The other co-authors are listed in the alphabetical order of their countries
Epiconcept
European Centre for Disease Prevention and Control
University of Tartu
Department of Genitourinary Medicine and Infectious Diseases (GUIDe)
University of Galway
Catholic University of the Sacred Heart
Fondazione Policlinico Universitario A
Paula Stradina Clinical University Hospital
Children's Clinical University Hospital
Instituto Nacional de Saúde Doutor Ricardo Jorge
Carol Davila University of Medicine and Pharmacy
Victor Babes National Institute
UIC Barcelona
SJD Barcelona Children's Hospital
Miguel Servet University Hospital (IIS Aragón)
Viljandi Hospital
Cantacuzino National Military-Medical Institute for Research and Development
Ciber of Epidemiology and Public Health CIBERESP

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

3 Atsauces (Scopus)

Kopsavilkums

COVID-19 vaccination recommendations include healthcare workers (HCWs). We measured COVID-19 vaccine effectiveness (CVE) of the autumn 2023 dose against laboratory-confirmed SARS-CoV-2 infection in a prospective cohort study of 1,305 HCWs from 13 European hospitals. Overall CVE was 22% (95% CI: -17 to 48), 49% (95% CI: -8 to 76) before and -11% (95% CI: -84 to 34) after the start of BA.2.86/JN.1 predominant circulation. Autumn 2023 COVID-19 vaccination led to a moderate-to-low reduction in SARS-CoV-2 infection incidence in HCWs. Monitoring of CVE is crucial for COVID-19 prevention.

Oriģinālvaloda	Angļu
Žurnāls	Eurosurveillance
Sējums	29
Izdevuma numurs	44
DOIs	https://doi.org/10.2807/1560-7917.ES.2024.29.44.2400680
Publikācijas statuss	Publicēts - 1 okt. 2024
Ārēji publicēts	Jā

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

3. IAM — Laba Veselība un Labbūtība

Piekļuve Dokumentiem

10.2807/1560-7917.ES.2024.29.44.2400680

Citi faili un saites

Saite uz publikāciju Scopus

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24”. Kopā tie veido unikālu nospiedumu.

Citēt šo

@article{1cca85e3cbad48ab94c74e65f17b787a,

title = "Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24",

abstract = "COVID-19 vaccination recommendations include healthcare workers (HCWs). We measured COVID-19 vaccine effectiveness (CVE) of the autumn 2023 dose against laboratory-confirmed SARS-CoV-2 infection in a prospective cohort study of 1,305 HCWs from 13 European hospitals. Overall CVE was 22\% (95\% CI: -17 to 48), 49\% (95\% CI: -8 to 76) before and -11\% (95\% CI: -84 to 34) after the start of BA.2.86/JN.1 predominant circulation. Autumn 2023 COVID-19 vaccination led to a moderate-to-low reduction in SARS-CoV-2 infection incidence in HCWs. Monitoring of CVE is crucial for COVID-19 prevention.",

keywords = "COVID-19, Europe, Healthcare workers, SARS-CoV-2, Vaccine effectiveness",

author = "\{VEBIS HCW VE study group\} and \{Collaborators in VEBIS HCW study group\} and Camelia Savulescu and Albert Prats-Uribe and Kim Brolin and Anneli Uusk{\"u}la and Colm Bergin and Catherine Fleming and Rita Murri and Viesturs Zvirbulis and Dace Zavadska and Vania Gaio and Popescu, \{Corneliu P.\} and Raluca Hrisca and Maria Cisneros and Miriam Latorre-Mill{\'a}n and Liis Lohur and Jonathan McGrath and Lauren Ferguson and \{De Gaetano Donati\}, Katleen and Ilze Abolina and Dagne Gravele and Ausenda Machado and Florescu, \{Simin Aysel\} and Mihaela Lazar and Pilar Subirats and \{Clusa Cuesta\}, Laura and Jacklyn Sui and Claire Kenny and Rosaria Santangelo and Dainis Krievins and Barzdina, \{Elza Anna\} and \{Valadas Henriques\}, Camila and Kosa, \{Alma Gabriela\} and Pohrib, \{Saftica Mariana\} and Carmen Mu{\~n}oz-Almagro and Ana Milagro and Sabrina Bacci and Anthony Nardone",

year = "2024",

month = oct,

day = "1",

doi = "10.2807/1560-7917.ES.2024.29.44.2400680",

language = "English",

volume = "29",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "44",

}

VEBIS HCW VE study group & Collaborators in VEBIS HCW study group 2024, 'Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24', Eurosurveillance, sēj. 29, Nr. 44. https://doi.org/10.2807/1560-7917.ES.2024.29.44.2400680

Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24. / VEBIS HCW VE study group; Collaborators in VEBIS HCW study group.
(gadā): Eurosurveillance, Sēj. 29, Nr. 44, 01.10.2024.

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

TY - JOUR

T1 - Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers

T2 - results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24

AU - VEBIS HCW VE study group

AU - Collaborators in VEBIS HCW study group

AU - Savulescu, Camelia

AU - Prats-Uribe, Albert

AU - Brolin, Kim

AU - Uusküla, Anneli

AU - Bergin, Colm

AU - Fleming, Catherine

AU - Murri, Rita

AU - Zvirbulis, Viesturs

AU - Zavadska, Dace

AU - Gaio, Vania

AU - Popescu, Corneliu P.

AU - Hrisca, Raluca

AU - Cisneros, Maria

AU - Latorre-Millán, Miriam

AU - Lohur, Liis

AU - McGrath, Jonathan

AU - Ferguson, Lauren

AU - De Gaetano Donati, Katleen

AU - Abolina, Ilze

AU - Gravele, Dagne

AU - Machado, Ausenda

AU - Florescu, Simin Aysel

AU - Lazar, Mihaela

AU - Subirats, Pilar

AU - Clusa Cuesta, Laura

AU - Sui, Jacklyn

AU - Kenny, Claire

AU - Santangelo, Rosaria

AU - Krievins, Dainis

AU - Barzdina, Elza Anna

AU - Valadas Henriques, Camila

AU - Kosa, Alma Gabriela

AU - Pohrib, Saftica Mariana

AU - Muñoz-Almagro, Carmen

AU - Milagro, Ana

AU - Bacci, Sabrina

AU - Nardone, Anthony

PY - 2024/10/1

Y1 - 2024/10/1

N2 - COVID-19 vaccination recommendations include healthcare workers (HCWs). We measured COVID-19 vaccine effectiveness (CVE) of the autumn 2023 dose against laboratory-confirmed SARS-CoV-2 infection in a prospective cohort study of 1,305 HCWs from 13 European hospitals. Overall CVE was 22% (95% CI: -17 to 48), 49% (95% CI: -8 to 76) before and -11% (95% CI: -84 to 34) after the start of BA.2.86/JN.1 predominant circulation. Autumn 2023 COVID-19 vaccination led to a moderate-to-low reduction in SARS-CoV-2 infection incidence in HCWs. Monitoring of CVE is crucial for COVID-19 prevention.

AB - COVID-19 vaccination recommendations include healthcare workers (HCWs). We measured COVID-19 vaccine effectiveness (CVE) of the autumn 2023 dose against laboratory-confirmed SARS-CoV-2 infection in a prospective cohort study of 1,305 HCWs from 13 European hospitals. Overall CVE was 22% (95% CI: -17 to 48), 49% (95% CI: -8 to 76) before and -11% (95% CI: -84 to 34) after the start of BA.2.86/JN.1 predominant circulation. Autumn 2023 COVID-19 vaccination led to a moderate-to-low reduction in SARS-CoV-2 infection incidence in HCWs. Monitoring of CVE is crucial for COVID-19 prevention.

KW - COVID-19

KW - Europe

KW - Healthcare workers

KW - SARS-CoV-2

KW - Vaccine effectiveness

UR - https://www.scopus.com/pages/publications/85208291983

U2 - 10.2807/1560-7917.ES.2024.29.44.2400680

DO - 10.2807/1560-7917.ES.2024.29.44.2400680

M3 - Article

C2 - 39484687

AN - SCOPUS:85208291983

SN - 1025-496X

VL - 29

JO - Eurosurveillance

JF - Eurosurveillance

IS - 44

ER -